Israeli biotech comes into its own

Article Abstract:

Israeli scientists are among the most prolific inventors in the world, spawning a biotechnology industry that has grown to number 130 companies. Rebif, Copaxaone, Exelon and Doxil are the four best selling prescription medicines in 2005 that are products of Israeli innovation leading to the sales of $3.5 billion.

Israel, Sales & consumption, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Biological products exc. diagnostic, Alzheimer Disease Controllers, Interferon, Innovations, Biotechnology industry, Biotechnology industries, Alzheimer's disease, Anti-Alzheimer's disease agents, Doxorubicin, Market size, Doxil (Medication), Exelon (Medication), Rebif (Medication)

---

Italy toasts Sardinia with SharDNA

Article Abstract:

Recently, the Sardinian geneticist Mario Pirastu announced the creation of Italy's first genomics company, SharDNA, which has been established to facilitate gene discovery among Sardinia's population.

Italy, Expanded capacity, plant expansion, DNA Probes, SharDNA

---

Genentech's 2nd IPO

Article Abstract:

Genentech's second initial public offering raised about $2 billion when it sold 20 million shares at $97 each.

United States, Organizational history, Biological Products, Genentech Inc., GNE

Similar abstracts:

• Abstracts: Liberalisation of international insurance operations. New financial statistics. Policy issues in insurance: investment, taxation, insolvency
• Abstracts: Beeld goes high tech. The Register's new audience
• Abstracts: Overcoming resistance to change. The change leader. Best practices in organizations experiencing extensive and rapid change
• Abstracts: "Cherish Our Children" effort promotes literacy locally. Sun-Sentinel
• Abstracts: KutMaster introduces cutlery tool center. Plum Pak introduces Bath Drain Repair Center. Kimberly-Clark introduces Cottonelle Fresh Rollwipes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.